Thymic Mucosa-Associated Lymphoid Tissue B-Cell Lymphoma in a Patient with Sjögren's Syndrome

DOI: https://doi.org/10.21203/rs.3.rs-739573/v1

Abstract

Background: Mucosa-associated lymphoid tissue (MALT) lymphoma rarely involves the thymus gland. About 5% of patients with Sjögren’s syndrome eventually develop lymphomas.

Case presentation: A 52-year-old woman with Sjögren's syndrome and immunologic thrombocytopenic purpura was found to have a mediastinal tumor. Preoperative examination revealed the patient suffered from a severe thrombocytopenia and even had a rare blood group: O D+ (D+c+c+E+E+). Resection of the mediastinal tumor via video-assisted thoracic surgery (VATS) following thoroughly preparation including thrombocyte transfusion. Histopathologic examination and immunohistochemistry of the thymus tumor were both consistent with mucosa-associated lymphoid tissue (MALT) lymphoma.

Conclusion:This rare case suggests that thymic MALT lymphoma can develop with an autoimmune disease such as Sjögren's syndrome, surgical resection of thymic tumor should be performed after careful preoperative preparation.

Background

Mucosa-associated lymphoid tissue (MALT) lymphoma is an extranodal low-grade B-cell lymphoma that occurs in MALT usually found in salivary glands, thyroid gland, lungs, urinary bladder, gastrointestinal tract, and skin.1 MALT lymphoma rarely involves the thymus gland. We recently treated a case of simultaneous MALT lymphoma in the thymus gland with Sjögren's syndrome and immunologic thrombocytopenic purpura. We hereby highlight our experience in this case.

Case Presentation

A 52-year-old woman was admitted to our hospital for treatment of thrombocytopenic purpura at the department of rheumatism and immunology. She had suffered from loss of teeth and dryness of the mouth for more than 10 years and also complained of dryness of eyes and arthralgia of proximal digital interosseous joints, wrist and knee joints in the last 5 years. 1 month ago, she had purpuric rashes of the lower extremities and blood test showed platelets counts was only 12*109/L in local hospital. The results for SS-A/Ro antibody and SS-B/La antibody were positive. Rheumatoid factor was positive (57.5 IU/mL), while serum levels of total protein, IgG, IgM, and IgA were normal. Eye examination revealed a positive Shirmer’s test (right eye:1 mm after 5 min and left eye:2 mm after 5 min). Salivary gland scintigraphy revealed no opacification of bilateral parotid and submandibular gland, suggesting no function of the glands (Fig. 1B). The patient fulfilled five of the six revised American–European Consensus Group Classification criteria2 in 2002 with xerostomia, xerophthalmia, positive Shirmer’s test, positive salivary gland scintigraphy, and positivity of SS-A/Ro antibody and SS-B/La antibodies, and was confirmed as having definite Sjögren’s syndrome. Further work-up included bone marrow puncture and chest CT in our hospital that revealed findings compatible with the diagnosis of immunologic thrombocytopenic purpura and thymic tumor. There is also found a special blood group: O D+ (D + c + c + E + E + and full 4 + reaction with anti-D), which has a rare prevalence in irregular antibody.3 Transfusion preparation was carefully done by blood bank. After platelets transfusion, hepatoprotection, corticosteroid therapy and intravenous gamma globulin, the patient was transferred into our department for elective operation to remove an anterior mediastinal tumor measuring 1.7*1.7 cm in size on the chest CT (Fig. 1A).

The video-assisted thoracic surgery (VATS) thymectomy was performed with red blood cell transfusion in January 18, 2019, following Multi-disciplinary Treatment (MDT) discussion by thoracic surgeons, transfusion doctor, anesthesiologist, hematologic and immunologic physician. Hence the diagnosis of the secondary thymic MALT associated with Sjögren's syndrome was also made. After a 30-month follow-up after the operation, the symptom of dry eyes and mouth improved dramatically, blood test shows platelets counts is 114*109/L and there is no evidence of tumor recurrence.

Discussion And Conclusions

Sjögren’s syndrome is a chronic autoimmune disease characterized by lymphocytic infiltration of the exocrine glands, specifically in the salivary glands, lacrimal glands and musculoskeletal system,resulting in xerostomia, xerophthalmia and arthralgia. Other systems or organs, such as respiratory, digestive, hematology system, and kidney, are also involves in this syndrome, leading to interstitial pneumonia, hepatic damage, thrombocytopenia, and renal dysfunction.4 Immunologic thrombocytopenic purpura is a common acquired autoimmune disease. Both antibody-mediated platelet destruction and impaired platelet production are involved in its pathogenesis. About 5% of patients with Sjögren’s syndrome eventually develop lymphomas, while patients with Sjögren’s syndrome having a 44-fold increased risk of developing non-Hodgkin’s lymphoma. MALT lymphoma arising in the thymus is extremely rare, only 37 cases have been reported before.1,5 Chronic B-cell stimulation by these antibodies may contribute to the development of MALT lymphoma. Immunologic disorders are strongly associated with thymic MALT lymphoma tumorigenesis and that thymic MALT lymphoma did not cause these disorders.6 The symptoms and antibody abnormalities could remain unimproved after thymectomy. Irregular antibodies screening is a routine preoperative test, because these harmful antibodies, for instance, anti-D, can result in severe hemolytic disease. In a retrospective review of 28 303 (21 327 Chinese) antenatal attendances from 1997 to 2001༌it is found that the prevalence of clinically significant antibodies amongst Chinese pregnant women is 0.27% and there is only one case which has anti-c + anti-E irregular antibodies among the 58 Chinese women.3 Tiwari et al.7 found that the incidence of irregular antibody varies across different clinical disciplines. Cardiology and cardio-thoracic surgery, hepatology, oncology are the most common clinical disciplines. According to our knowledge, however, the association between irregular antibody and thymic MALT lymphoma is unclear.

As for the surgical treatment of the patient, there is many critical points to achieve a well performance. Firstly, perioperative examination and preparation for clinical diagnosis and operative conditions, such as transfusion preparation. Then, for complicated disease, especially in old people with many comorbidities, MDT should be taken into consideration by enough specialized doctor, such as surgeons, physicians, radiologists and anesthesiologists. Finally, postoperative management should focus on surgical complications, for instance, bleeding after operation due to wound errhysis and stress to decrease the platelets counts. To monitor postoperative condition, patient was warned to routine assessment in the outpatient clinic.

Here we report one case, to our knowledge, that is the first case of thymic MALT lymphoma associated with 2 rare parathymic syndromes: Sjögren's syndrome, immunologic thrombocytopenic purpura and accompanying a rare blood group.

Abbreviations

Mucosa-associated lymphoid tissue

MALT; Multi-disciplinary treatment:MDT; Video-assisted thoracic surgery:VATS

Declarations

Ethics approval and consent to participate:

The study was approved by the institutional review board (IRB) of Peking University People’s Hospital. The procedure were performed in accordance with the Declaration of Helsinki and relevant policies in China.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. 

Availability of data and materials

Data sharing not applicable to this article as no datasets were generated or analysed during the current study.

Competing interests

The authors have no conflicts of interest to declare.

Funding

None.

Authors' contributions

KL searched and analyzed the patient data regarding the autoimmune disease, and was a major contributor in writing the manuscript. FY and JW performed the operation and histological examination of the thymus. JZ review and revised the manuscript. All authors read and approved the final manuscript.

Authors' information (optional)

None.

Acknowledgements

Not applicable.

References

  1. Shimizu K, Yoshida J, Kakegawa S, et al. Primary thymic mucosa-associated lymphoid.
  2. tissue lymphoma: diagnostic tips. J Thorac Oncol. 2010;5:117 – 21;. doi:10.1097/JTO.0b013e3181c07df8.
  3. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome:a.
  4. revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8. doi:10.1136/ard.61.6.554.
  5. Lee CK, Ma ES, Tang M, et al. Prevalence and specificity of clinically significant red.
  6. cell alloantibodies in Chinese women during pregnancy–a review of cases from 1997 to 2001.Transfus Med. 2003;13:227 – 31;doi: 10.1046/j.1365-3148.2003.00445.x.
  7. P. J. Venables. Sjögren's syndrome. Best Practice & Research: clinical Rheumatology 2004; 18:3702.
  8. Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in.
  9. sicca syndrome. Ann Intern Med. 1978;89:888–92. doi:10.7326/0003-4819-89-6-888.
  10. Kurabayashi A, Mmatsumoto I. Thymic mucosa-associated lymphoid tissue lymphoma with immunoglobulin-storing histiocytosis in Sjogren's syndrome. Pathol Int. 2010;60:125 – 30;. doi:10.1111/j.1440-1827.2009.02486.x.
  11. Tiwari AK, Pandey P, Sharma J, et al. Incidence of clinically significant antibodies in patients and healthy blood donors: a prospective cross-sectional study from a tertiary healthcare center in India. Transfus Apher Sci. 2014;50:230–4. doi:10.1016/j.transci.2013.08.008.